Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ROR1 CAR-T cells |
Synonyms | |
Therapy Description |
ROR1 CAR-T cells are autologous T-lymphocytes engineered to express anti-ROR1 single-chain variable fragment linked to CD28 transmembrane domain, and either 4-1BB/CD3zeta or CD28/CD3zeta signaling domains, which potentially induces immune response against ROR1-expressing tumor cells, leading to apoptosis and tumor cell lysis (PMID: 31415244). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ROR1 CAR-T cells | autologous ROR1-CAR-T cells | ROR1 CAR-T cells are autologous T-lymphocytes engineered to express anti-ROR1 single-chain variable fragment linked to CD28 transmembrane domain, and either 4-1BB/CD3zeta or CD28/CD3zeta signaling domains, which potentially induces immune response against ROR1-expressing tumor cells, leading to apoptosis and tumor cell lysis (PMID: 31415244). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|